Dr. Kao is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
4330 Wornall Rd
Ste 2000
Kansas City, MO 64111Phone+1 816-931-1883Fax+1 816-756-3645
Summary
- Dr. Andrew Kao is a cardiologist in Kansas City, MO and is affiliated with multiple hospitals in the area, including Lee's Summit Medical Center, Saint Luke's East Hospital, Saint Luke's Hospital of Kansas City, Saint Luke's North Hospital - Barry Road, St Edward Mercy Medical Center, Hedrick Medical Center, Saint Luke's South Hospital, and Mercy Hospital Joplin. He received his medical degree from University of Chicago Pritzker School of Medicine and has been in practice 29 years. He is board certified in adult cardiology and advanced heart failure & cardiac transplantation . He has interest in the treatment of central sleep apnea and is also the medical director of the cardiopulmonary exercise laboratory and has been involved in numerous industry-sponsored and NIH-sponsored multicenter triaals.
Education & Training
- Duke University HospitalFellowship, Cardiovascular Disease, 1991 - 1994
- University of MinnesotaResidency, Internal Medicine, 1988 - 1991
- University of Chicago Division of the Biological Sciences The Pritzker School of MedicineClass of 1988
Certifications & Licensure
- KS State Medical License 2004 - 2025
- MO State Medical License 2004 - 2025
- American Board of Internal Medicine Advanced Heart Failure and Transplant Cardiology
- American Board of Internal Medicine Cardiovascular Disease
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification NextGen Ambulatory EHR, NextGen Healthcare, 2012-2013
- Super Doctor SuperDoctors.com
Clinical Trials
- IMAGE: A Comparison of AlloMap Molecular Testing and Traditional Biopsy-based Surveillance for Heart Transplant Rejection Start of enrollment: 2005 Jan 01
- Efficacy and Safety Study of Genetically Targeted Enzyme Replacement Therapy for Advanced Heart Failure Start of enrollment: 2007 Mar 01
- A Pivotal Trial to Establish the Efficacy and Long-term Safety of the Parachute Implant System Start of enrollment: 2012 Dec 01
- Join now to see all
Publications & Presentations
PubMed
- 344 citationsGene-Expression Profiling for Rejection Surveillance after Cardiac TransplantationM.X. Pham, Jeffrey J. Teuteberg, Abdallah G. Kfoury, Randall C. Starling, Mario C. Deng
The New England Journal of Medicine. 2010-05-12 - 20 citationsMyocardial perfusion, function, and dyssynchrony in patients with heart failure: baseline results from the single-photon emission computed tomography imaging ancillary...Allen E. Atchley, Dalane W. Kitzman, David J. Whellan, Ami E. Iskandrian, Stephen J. Ellis
American Heart Journal. 2009-10-01 - 28 citationsEffect of atorvastatin on postcardiac transplant increase in low-density lipoprotein cholesterol reduces development of intimal hyperplasia and progression of endothel...Vincent See, David DeNofrio, Lee R. Goldberg, Gene Chang, Brett M. Sasseen
The American Journal of Cardiology. 2003-07-01
Press Mentions
- Michigan Man Now Able to Spend More Time with Family After Heart Transplant Surgery at St. Luke’sDecember 24th, 2019
- Clinical Trial Uses 'Zipper' to Help Heart BeatJune 27th, 2018
- Heart Transplant Recipient on the Run Again Following SurgeryApril 12th, 2016
- Join now to see all
Professional Memberships
- Member
- Heart Failure Society of AmericaMember
- Member
- International Society of Heart and Lung TransplantationMember
- United Network of Organ SharingMember
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: